Questions remain surrounding Oxford vaccine trial pause

Jeremy HagueSeptember 15, 2020

0 1 minute read

AstraZeneca headquarters in Sydney. Photo: NCA NewsWire/Bianca De Marchi

Scientists around the globe celebrated news the University of Oxford would restart the trial for its COVID-19 vaccine candidate, but some called for more transparency surrounding the pause while others backed the decision to not detail the illness that prompted it.

Please login below to view content or subscribe now.